Hepatocellular Carcinoma after Treatment of Cirrhotic Hepatitis C Virus Patients with Direct Acting Antiviral Treatment | ||||
Azhar International Journal of Pharmaceutical and Medical Sciences | ||||
Article 2, Volume 5, Issue 1, January 2025, Page 17-26 PDF (310.47 K) | ||||
Document Type: Review Articles | ||||
DOI: 10.21608/aijpms.2024.181518.1183 | ||||
![]() | ||||
Authors | ||||
Nourhan Fekry ![]() | ||||
1Sinbillawine General Hospital Daqahlia, Egypt | ||||
2Department of Internal Medicine (Hepato gastroentrology) Faculty of Medicine, Mansoura University, Egypt | ||||
3Department of Clinical Pharmacy, Faculty of Pharmacy (Girls) Al-Azhar University, Cairo, Egypt | ||||
4Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt | ||||
Abstract | ||||
Earlier treatment plans based on the use of interferon (IFN) were characterised by a sustained virological response (SVR) of 40–50%., but Since direct acting anti viral therapy (DAAs) introduced to treat chronic hepatitis (C) patients , result in interesting high rate of sustained virologic response by 95% with a good safety profile with reduction in death rate as well as hepatocellular carcinoma (HCC) ,despite this high rate of SVR the risk of (HCC) doesn't eliminated , data puplished in 2016 were a source of worry regarding the (HCC) appear post treatment either de novo or recurrence , in addition tumour characteristic after DAAs more aggressive , Discovered that following DAAs tumours displayed aggressive behaviour, had a larger number of nodules, and had extrahepatic metastases, demonstrating that cancer growth is faster than expected in these patients, this is because The use of powerful IFN-free DAAs treatments may result in rapid viral suppression and reduce inflammatory cytokine responses . | ||||
Keywords | ||||
Hepatitis C virus; Sustained virologic response; Direct-acting antiviral therapy; Hepatocellular carcinoma; Liver cirrhosis | ||||
Statistics Article View: 213 PDF Download: 142 |
||||